Geneva Pharmaceuticals Inc.

After this summer's failed merger talks between the two companies, Galen's three-pronged deal with US-based generics play Barr Laboratories might be the next best thing for Galen investors. At little

Despite important differences between generics and proprietary businesses, generics companies are betting that they can manage both under one roof. by Wendy Diller The news would have been music to an

On April 29, Biovail Corp. , the Canadian specialty pharmaceutical company, saw its shares plummet over 20%, wiping almost a billion dollars from its market value in just one day. A rare sell recom

3206 Tower Oaks Boulevard, Suite 310 Rockville, MD 20852 DrGlobe.com 29, rue de la Coulouvrenière CH-1204 Geneva, Switzerland RxMarketplace.com Inc. 500 South Arthur Avenue, Suite 700 Louisville, CO 8